Stock Analysis on Net
Stock Analysis on Net

Becton, Dickinson & Co. (NYSE:BDX)

This company has been moved to the archive! The financial data has not been updated since May 5, 2022.

Analysis of Revenues 

Microsoft Excel

Revenues as Reported

Becton, Dickinson & Co., income statement, revenues

US$ in millions

Microsoft Excel
12 months ended: Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
Medical 9,479 8,680 9,064 8,616 7,419 7,965
Life Sciences 6,530 4,675 4,300 4,330 3,988 3,829
Interventional 4,239 3,762 3,926 3,037 686 689
Revenues 20,248 17,117 17,290 15,983 12,093 12,483

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

Item Description The company
Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Becton, Dickinson & Co. revenues decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.